0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Childhood History of Resolved Glomerular Disease and Risk of Hypertension During Adulthood FREE

Asaf Vivante, MD1; Gilad Twig, MD, PhD1; Amir Tirosh, MD, PhD2; Karl Skorecki, MD3; Ronit Calderon-Margalit, MD, MPH4
[+] Author Affiliations
1Talpiot Medical Leadership Program, IDF Medical Corps, Tel-Hashomer, Israel
2Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, Boston, Massachusetts
3Department of Nephrology, Rappaport Faculty of Medicine and Research Institute, Technion, Israel
4Hadassah-Hebrew University Braun School of Public Health, Jerusalem, Israel
JAMA. 2014;311(11):1155-1157. doi:10.1001/jama.2013.284310.
Text Size: A A A
Published online

Most children who develop glomerular disease have a favorable prognosis with complete resolution of all signs and symptoms. Yet the long-term sequelae of resolved childhood glomerular disease are incompletely understood. We assessed whether a medical history of resolved childhood glomerular disease confers a future risk for hypertension.

We conducted a cohort study of young healthy men seen in the Israel Defense Forces Medical Corps Staff Periodic Examination Center (SPEC)1 where periodic examinations of career military personnel are conducted. All men had a baseline evaluation conducted prior to recruitment at age 17 years1,2 during which the diagnosis of resolved childhood glomerular disease was determined. This included childhood acute glomerulonephritis or nephrotic syndrome (Table 1; diagnostic criteria appear in footnote b). We excluded men with baseline diagnoses of unresolved childhood glomerular disease, hypertension, diabetes, active rheumatic diseases, or any other kidney or urinary tract disorders (n = 959).

Table Graphic Jump LocationTable 1.  Study Population Characteristics According to Childhood Medical History

Participants were followed up from the time of medical assessment during adolescence (1970-1997) through the SPEC visits (1994-2010) until the diagnosis of hypertension (systolic >140 mm Hg or diastolic >90 mm Hg), retirement from service, or December 31, 2010, whichever came first. The definition of hypertension (Table 2; see footnote a) was based on standard protocols as previously described.1

Table Graphic Jump LocationTable 2.  Incident Hypertension in Adulthood According to Childhood Medical History of Resolved Glomerular Diseasea

Associations were estimated using Cox proportional hazards models. A second set of analyses counted time from first SPEC visit and excluded diagnoses made before or on the first visit when dates of diagnoses might be inaccurate. Similar analyses were conducted using the estimated glomerular filtration rate (eGFR) from the Modification of Diet in Renal Disease Study equation; levels below 60 and 70 mL/min/1.73 m2 were used as outcomes.

All analyses were conducted using SPSS software version 21.0 (SPSS Inc). Two-sided P values of less than .05 were considered statistically significant. The Israel Defense Forces review board approved the study and waived the requirement for informed consent.

The study included 38 144 male career personnel, of whom 264 were diagnosed with a medical history of resolved childhood glomerular disease (Table 1). During a mean follow-up of 18 years (mean [SD] age, 35.8 [7.05] years), 2856 participants developed hypertension; 13.6% (n = 36) of participants with a medical history of resolved childhood glomerular disease and 7.4% (n = 2820) of those without such history, yielding a crude hazard ratio (HR) of 1.63 (95% CI, 1.17-2.26) and an HR adjusted for age and body mass index of 1.67 (95% CI, 1.20-2.31). Excluding those diagnosed before the first SPEC visit had a negligible effect on these HR estimates (Table 2).

Creatinine values were available for 76% of the cohort. During follow-up, 2.0% (n = 4) of those with a medical history of resolved childhood glomerular disease and 1.1% (n = 308) of those without such a history had an eGFR below 60 mL/min/1.73 m2, yielding an age-adjusted HR of 1.53 (95% CI, 0.57-4.10). Thirteen percent of those with and 10.4% of those without a history of glomerular disease had an eGFR below 70 mL/min/1.73 m2 (age-adjusted HR, 1.03; 95% CI, 0.70-1.51).

In this study, resolved childhood glomerular disease was associated with subsequent risk of hypertension in a cohort of young healthy adult men. In addition to the selected cohort, the limitations include lack of information on the exact glomerular histopathologic injury during childhood. Nevertheless, all glomerular conditions were clinically resolved and, by the age of 17 years, participants were free of symptoms and signs for at least 2 years. The interpretation is also limited by the young age of the study population at the end of follow-up.

The 2 most common resolved childhood glomerular diseases are acute glomerulonephritis and steroid-sensitive nephrotic syndrome. Previous large case series36 showed excellent long-term prognoses for children with these conditions. In agreement with our findings, 3.5% to 21.1% of patients with glomerulonephritis3,4 and 2.6% with nephrotic syndrome5 have been reported to develop either persistent urinary abnormalities or hypertension.

Our results suggest that glomerular disease during childhood may represent a continuum of kidney injury that begins well before sufficient loss of excretory kidney function can be measured with standard laboratory tests, such that the first manifestation may be adult hypertension.

Section Editor: Jody W. Zylke, MD, Senior Editor.

Corresponding Author: Asaf Vivante, MD, Talpiot Medical Leadership Program, IDF Medical Corps, Sheba Medical Center, Tel Hashomer 52621, Israel (asafvivante@gmail.com).

Author Contributions: Drs Vivante and Calderon-Margalit had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Vivante, Twig, Skorecki, Calderon-Margalit.

Acquisition of data: Vivante, Tirosh, Calderon-Margalit.

Analysis and interpretation of data: Vivante, Tirosh, Skorecki, Calderon-Margalit.

Drafting of the manuscript: Vivante, Calderon-Margalit.

Critical revision of the manuscript for important intellectual content: Vivante, Twig, Tirosh, Skorecki, Calderon-Margalit.

Statistical analysis: Vivante, Tirosh, Calderon-Margalit.

Administrative, technical, and material support: Vivante.

Study supervision: Vivante, Skorecki.

Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Skorecki reported serving as a consultant to Elsevier. Dr Calderon-Margalit reported receiving travel reimbursement from COST. No other disclosures were reported.

Funding/Support: Access to anonymized databases was provided by the Israeli Defense Forces Medical Corps.

Role of the Sponsor: The Israeli Defense Forces Medical Corps had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: We thank Dorit Tzur, MBA (IDF Medical Corps), for technical support and thoughtful comments. She was not compensated for her contributions.

Tirosh  A, Afek  A, Rudich  A,  et al.  Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension. 2010;56(2):203-209.
PubMed   |  Link to Article
Vivante  A, Golan  E, Tzur  D,  et al.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012;172(21):1644-1650.
PubMed   |  Link to Article
Potter  EV, Lipschultz  SA, Abidh  S, Poon-King  T, Earle  DP.  Twelve to seventeen-year follow-up of patients with poststreptococcal acute glomerulonephritis in Trinidad. N Engl J Med. 1982;307(12):725-729.
PubMed   |  Link to Article
Perlman  LV, Herdman  RC, Kleinman  H, Vernier  RL.  Poststreptococcal glomerulonephritis: a ten-year follow-up of an epidemic. JAMA. 1965;194(1):63-70.
PubMed   |  Link to Article
Trompeter  RS, Lloyd  BW, Hicks  J, White  RH, Cameron  JS.  Long-term outcome for children with minimal-change nephrotic syndrome. Lancet. 1985;1(8425):368-370.
PubMed   |  Link to Article
Koskimies  O, Vilska  J, Rapola  J, Hallman  N.  Long-term outcome of primary nephrotic syndrome. Arch Dis Child. 1982;57(7):544-548.
PubMed   |  Link to Article

Figures

Tables

Table Graphic Jump LocationTable 1.  Study Population Characteristics According to Childhood Medical History
Table Graphic Jump LocationTable 2.  Incident Hypertension in Adulthood According to Childhood Medical History of Resolved Glomerular Diseasea

References

Tirosh  A, Afek  A, Rudich  A,  et al.  Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension. 2010;56(2):203-209.
PubMed   |  Link to Article
Vivante  A, Golan  E, Tzur  D,  et al.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012;172(21):1644-1650.
PubMed   |  Link to Article
Potter  EV, Lipschultz  SA, Abidh  S, Poon-King  T, Earle  DP.  Twelve to seventeen-year follow-up of patients with poststreptococcal acute glomerulonephritis in Trinidad. N Engl J Med. 1982;307(12):725-729.
PubMed   |  Link to Article
Perlman  LV, Herdman  RC, Kleinman  H, Vernier  RL.  Poststreptococcal glomerulonephritis: a ten-year follow-up of an epidemic. JAMA. 1965;194(1):63-70.
PubMed   |  Link to Article
Trompeter  RS, Lloyd  BW, Hicks  J, White  RH, Cameron  JS.  Long-term outcome for children with minimal-change nephrotic syndrome. Lancet. 1985;1(8425):368-370.
PubMed   |  Link to Article
Koskimies  O, Vilska  J, Rapola  J, Hallman  N.  Long-term outcome of primary nephrotic syndrome. Arch Dis Child. 1982;57(7):544-548.
PubMed   |  Link to Article

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Example 1: Diabetes and Target Blood Pressure